Medicines & devices
Explore medicines and devices by name or category. Medicines are sourced through a Hong Kong-based purchase channel, subject to clinical review. Information only — not medical advice or a supply guarantee.
Request Eligibility AssessmentNo matching entries. Try another name or clear the filters.
Lung cancer 8
Breast cancer 5
Gastrointestinal & colorectal 4
Genitourinary (prostate / kidney / bladder) 10

ADSTILADRIN
nadofaragene firadenovec-vncg纳度法拉非

AKEEGA
niraparib and abiraterone acetate尼拉帕尼和醋酸阿比特龙

Balversa
erdafitinib厄达替尼

CAMCEVI
leuprolide mesylate亮丙瑞林

FOTIVDA
tivozanib替沃扎尼

INLEXZO
gemcitabine intravesical system吉西他滨

JEVTANA
cabazitaxel卡巴他赛

Proleukin
aldesleukin阿地白介素

Rubraca
rucaparib卢卡帕利

Torisel
temsirolimus替西罗莫司
Gynecologic 2
Hepatobiliary (liver / bile duct) 5
Blood cancers (leukemia / lymphoma / myeloma) 27

Agrylin
anagrelide阿那格雷

APHEXDA
motixafortide莫替沙福肽

BRUKINSA
zanubrutinib泽布替尼

CALQUENCE
acalabrutinib阿卡替尼

Columvi
glofitamab格菲妥单抗

DARVIAS
darinaparsin达利帕辛

ELREXFIO
elranatamab埃纳妥单抗

EPKINLY
epcoritamab艾可利单抗

EZHARMIA
valemetostat伐美司他

GLEOSTINE
lomustine洛莫司汀

ICLUSIG
ponatinib普纳替尼

IDHIFA
enasidenib恩西地平

Jaypirca
pirtobrutinib吡托布鲁替尼

Lunsumio\mosunetuzumab\莫妥珠单抗
mosunetuzumab莫妥珠单抗

Monjuvi
tafasitamab塔法西妥单抗

MYLOTARG
gemtuzumab ozogamicin吉妥珠单抗

OJJAARA
momelotinib莫洛替尼

Reblozyl
luspatercept罗特西普

Revuforj
revumenib瑞美尼布

Rezlidhia
olutasidenib奥鲁萨替尼

Rytelo
imetelstat伊美司他

SCEMBLIX
asciminib阿昔米尼

TALVEY
talquetamab塔奎妥单抗

TECVAYLI
teclistamab特立妥单抗

VALCHLOR
mechlorethamine盐酸氮芥

VANFLYTA
quizartinib奎扎替尼

ZOLINZA
vorinostat伏立诺他
Melanoma & skin cancers 5
Neuro-oncology 3
Sarcoma & connective tissue 4
Thyroid & other solid tumors 3
Neurology & neurodegenerative 17

AIMOVIG
erenumab依瑞奈尤单抗

AMVUTTRA
vutrisiran伏替司兰

DAYBUE
trofinetide曲芬尼肽

Imaavy
nipocalimab尼泊卡利单抗

KISUNLA
donanemab多纳单抗

LEMTRADA
alemtuzumab阿仑单抗

Leqembi
lecanemab乐卡奈单抗

Nurtec\rimegepant\瑞美吉泮
rimegepant瑞美吉泮

Ongentys
opicapone奥匹卡朋

Rozebalamin
mecobalamin甲钴胺

VUITY
pilocarpine毛果芸香碱

VYALEV
foscarbidopa and foslevodopa福斯卡比多巴/福斯左旋多巴

VYVGART
efgartigimod alfa艾加莫德

XADAGO
safinamide沙芬酰胺

ZILBRYSQ
zilucoplan泽卢克布仑钠

ZUNVEYL
benzgalantamine苯加兰他敏

诺华Xiidra
lifitegrast立非司特
Metabolic & cardiovascular 4
Other specialty & rare disease 42

AGAMREE
vamorolone伐莫洛龙

ALUNBRIG
brigatinib布格替尼

BAVENCIO
avelumab阿维鲁单抗

Binimetinib
binimetinib比美替尼

BRAFTOVI
encorafenib康奈非尼

CABLIVI
caplacizumab卡拉西珠单抗

cabozantinib
cabozantinib卡博替尼

Enhertu
trastuzumab deruxtecan德曲妥珠单抗

Filspari
sparsentan司帕生坦

ILARIS
canakinumab卡那单抗

ISTURISA
osilodrostat奥西洛司他

JASCAYD
nerandomilast那米司特

JEMPERLI 多塔利单抗
dostarlimab多塔利单抗

Kineret
anakinra阿那白滞素

Kinpeygo 布地奈德缓释胶囊
budesonide布地奈德肠溶胶囊

Koselugo司美替尼
selumetinib司美替尼

LEQVIO
inclisiran英克司兰

LITFULO
ritlecitinib利特昔替尼

Ohtuvayre
ensifentrine恩司芬群

Onivyde 安能得
irinotecan liposome伊立替康脂质体

PADCEV
enfortumab vedotin维恩妥尤单抗

Piqray
alpelisib阿培利司

Polivy泊洛妥珠单抗
polatuzumab vedotin维泊妥珠单抗

PULMOZYME
dornase alfa阿法妥拉酶

REZUROCK
belumosudil贝舒地尔

Saphnelo
anifrolumab-fnia阿尼鲁单抗

Strensiq
asfotase alfa阿福特酶阿法

Sunlenca
lenacapavir来那卡帕韦

TOBI
tobramycin妥布霉素

Trodelvy戈沙妥珠单抗
sacituzumab govitecan戈沙妥珠单抗

VOQUEZNA
vonoprazan伏诺拉生

WELIREG
belzutifan贝舒替凡

XENPOZYME
olipudase alfa奥利泼达酶阿尔法

劳拉替尼
lorlatinib劳拉替尼

卢比替定
lurbinectedin芦比替定

去纤苷
defibrotide去纤苷

熊猫血RhoGAM
Rho(D) immune globulin抗Rho(D)免疫球蛋白

索托拉西布
sotorasib索托拉西布

西米普利单抗
cemiplimab西米普利单抗

辉瑞新冠特效药:奈玛特韦片
nirmatrelvir/ritonavir奈玛特韦片/利托那韦片

阿兹夫定
azvudine阿兹夫定

雷莫芦单抗
ramucirumab雷莫芦单抗
Special-Import Medical Devices 5

German Apheresis / 德机单重血液净化
Apheresis and blood purification system血浆吸附与单重血液净化系统

German DFPP / 德机双重血液净化
Double filtration plasmapheresis (DFPP) system双重过滤血浆置换/净化系统 (DFPP)

Japanese DFPP / 日机双重血液净化
Selective lipid adsorption and double filtration plasmapheresis system选择性脂质吸附与双重血浆净化系统

ET Deep Body Hyperthermia / ET体核热疗
Whole-body deep hyperthermia / Oncological thermotherapy system全身深部核热疗/肿瘤辅助热疗系统
TumorFisher CTC Biopsy / 肿瘤捕手液体活检
Circulating Tumor Cell (CTC) isolation and detection device循环肿瘤细胞 (CTC) 磁珠法捕获与检测系统
About the Hong Kong purchase channel
Uwell Cloud helps arrange access to selected globally approved oncology and specialty medicines that are not yet distributed through mainland China's retail pharmacy network. These medicines are sourced through a Hong Kong-based purchase channel; clinical administration support in China can be coordinated on request. Explore the active catalog below.
Check eligibility for a specific drug or therapy
Submit your diagnosis and recent reports through our secure pre-screening. Our coordinators and partner-hospital specialists will confirm eligibility, the clinical pathway, and a personalized quote.
Request Eligibility Assessment









































